ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 128

A Rapid 4- Joint Ultrasonographic Score to Daily Monitoring Disease Activity in Patients with Rheumatoid Arthritis: Validity and Sensitivity to Change

Tomas Cazenave1, Christian A. Waimann2, Gustavo Citera3 and Marcos G. Rosemffet4, 1Junin 519 1ero B, IREP, Buenos Aires, Argentina, 2Rheumatology, Hospital Olavarria, Olavarria, Argentina, 3Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 4Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Disease Activity, rheumatoid arthritis (RA) and ultrasonography

  • Tweet
  • Email
  • Print
Session Information

Title: Imaging of Rheumatic Diseases: Ultrasound

Session Type: Abstract Submissions (ACR)

Background/Purpose

Ultrasound has demonstrated to be a sensitivity and specific tool to assess patients with Rheumatoid Arthritis (RA). However, the feasibility of this technology in daily clinical practice is still under debate. The purpose of our study was to evaluate the validity and sensitivity to change of a rapid 4-joint ultrasonographic score that could be applied to daily monitoring disease activity in patients with RA.

Methods

We included patients with RA (ACR/EULAR 2010). Data was collected at baseline, 3 and 12 months. Each patient underwent clinical (DAS28) and ultrasonographic (US) evaluation of 28-joints. Power Doppler (PD) and gray scale (GS) were graded from 0 to 3, according to OMERACT standards. Three ultrasonographic scores were calculated: 4-joints (bilateral radio and intracarpal joint and second metacarpophalangeal), 6-joints (4-joints plus bilateral fifth metatarsophalangeal), and 28- joints. US scores come as the result of the addition of PD and GS score, with a total score ranged from 0 – 36, 0 – 48, 0 – 174, respectively. We evaluated psychometric properties of 4-joints score in comparison with others US scores, including criterion, construct validity and internal consistency (Cronbach’s α coefficients). Sensitivity to change was measured at 12 months using standardized response mean (SRM) and classified according Cohen’s effect size.  The minimal important change (MIC) was defined as a change of 1.96 times the standard error of measurement.   

Results

49 patients were included. All patients completed annual visits. Mean age was 53 ± 10 years, 85% were female, and disease duration was 8 ± 5 years. Baseline DAS28 score was 4.8 ± 1.5. Mean 4-joints ultrasonographic score was 12 ± 6 (Doppler subscale 5 ± 3; Synovitis subscale 6 ± 3). The score showed an acceptable confiability and a moderate to good correlation with DAS28, 6 and 28 joints US scores (Table 1). The 4-joint US examination was able to measures change in clinical status (SRM=0.98, large effect size).  A change in score ≥5 was defined as a minimal important change. The ultrasonographic evaluation of 4-joint US score was fast, taking 5 minutes per patient, in comparison with 8 and 35 minutes for 6 and 28 joints scores, respectively.

Table 1.

US score

Baseline mean±SD

Floor effect

Celling effect

Cronbach’s α coefficients

MIC

SRM

Correlation matrix (r)

US 6-joints score

US 28-joints score

DAS28

4-joints

12 ± 6

0%

0%

0.84

4.9

0.98

0.96*

0.80*

0.60*

6-joints

14 ± 7

0%

0%

0.84

5.5

0.94

—–

0.83*

0.65*

28-joints

34 ± 20

0%

0%

0.94

5.0

0.72

—–

—–

0.77*

* P-value <0.05

Conclusion

A reduced US score of 4 joints showed to be a valid tool to detect and monitor disease activity in patients with RA. The quickness and high ability to detect clinical changes make this score a feasible and useful tool in daily rheumatology practice


Disclosure:

T. Cazenave,
None;

C. A. Waimann,
None;

G. Citera,
None;

M. G. Rosemffet,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-rapid-4-joint-ultrasonographic-score-to-daily-monitoring-disease-activity-in-patients-with-rheumatoid-arthritis-validity-and-sensitivity-to-change/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology